In Brief: Electronic QC controls
This article was originally published in The Gray Sheet
Executive Summary
Electronic QC controls: i-Stat's hand-held, automated blood chemistry analyzer was not referenced in an Oct. 13 Health Care Financing Administration memo sent to HCFA regional offices to "clarify and define" surveyor guidelines on electronic quality control in quantitative automated analyzers. Another undated version of the memo, cited by "The Gray Sheet" (Oct. 30, I&W-1), referenced the i-Stat device. The Oct. 13 memo notes that the use of electronic quality controls in quantitative automated analyzers "will be re-evaluated for the final, final" regulations for the Clinical Laboratory Improvement Amendments of 1988...
You may also be interested in...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.